Variant report
Variant | esv3402541 |
---|---|
Chromosome Location | chr20:16056352-16061450 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs201754028 | chr20:16056403-16056404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs550248114 | chr20:16056422-16056423 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs372210329 | chr20:16056429-16056430 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs574486465 | chr20:16056447-16056448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs563483295 | chr20:16056471-16056472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs376720688 | chr20:16056526-16056527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs369814712 | chr20:16056541-16056542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs541783395 | chr20:16056581-16056582 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs188280082 | chr20:16056602-16056603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs529353751 | chr20:16056645-16056646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs191946123 | chr20:16056691-16056692 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs546097580 | chr20:16056699-16056700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs564687972 | chr20:16056713-16056714 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs112174940 | chr20:16056732-16056733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs150659097 | chr20:16056757-16056758 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs6075001 | chr20:16056766-16056767 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs529715331 | chr20:16056790-16056791 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs6080114 | chr20:16056836-16056837 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs566667104 | chr20:16056853-16056854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs369986839 | chr20:16056871-16056872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs6034375 | chr20:16056900-16056901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs370125394 | chr20:16056901-16056902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs1745931 | chr20:16056902-16056903 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs75847576 | chr20:16056906-16056907 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs6034376 | chr20:16056907-16056908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs71192318 | chr20:16056926-16056927 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs112089825 | chr20:16056952-16056953 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs113839470 | chr20:16056956-16056957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs570307621 | chr20:16057022-16057023 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs184505701 | chr20:16057046-16057047 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs547586978 | chr20:16057138-16057139 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs189215646 | chr20:16057213-16057214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs79629501 | chr20:16057239-16057240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs181868563 | chr20:16057345-16057346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs185785183 | chr20:16057351-16057352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs1237495 | chr20:16057410-16057411 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs75527999 | chr20:16057423-16057424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs571199551 | chr20:16057433-16057434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs147464102 | chr20:16057439-16057440 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs139864768 | chr20:16057570-16057571 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs376547305 | chr20:16057629-16057630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs375804940 | chr20:16057637-16057638 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs189025244 | chr20:16057669-16057670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs145329502 | chr20:16057698-16057699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs527633416 | chr20:16057707-16057708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs145648889 | chr20:16057734-16057735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs398121214 | chr20:16057738-16057739 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs78683651 | chr20:16057739-16057740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs537654372 | chr20:16057786-16057787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs549538633 | chr20:16057789-16057790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 16397240 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Wilms tumour | 21544195 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 16272173 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 19627613 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Colorectal cancer | 21645411 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Glaucoma | 21310917 | CNVD |
Alagille syndrome | 22470819 | CNVD |
Lung cancer | 16773561 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Alagille syndrome | 17576883 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Kabuki syndrome | 21720541 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Neurocytoma | 17123091 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21364760 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:16052800-16057200 | Weak transcription | Primary B cells from cord blood | blood |
2 | chr20:16053400-16057000 | Weak transcription | Primary B cells from peripheral blood | blood |
3 | chr20:16057000-16060400 | Enhancers | Primary B cells from peripheral blood | blood |
4 | chr20:16057200-16059000 | Enhancers | Primary B cells from cord blood | blood |
5 | chr20:16058800-16059400 | Enhancers | GM12878-XiMat | blood |
6 | chr20:16059000-16059400 | Flanking Active TSS | Primary B cells from cord blood | blood |
7 | chr20:16059400-16061600 | Enhancers | Primary B cells from cord blood | blood |
8 | chr20:16059400-16062000 | Weak transcription | GM12878-XiMat | blood |
9 | chr20:16060400-16060800 | Weak transcription | Primary B cells from peripheral blood | blood |
10 | chr20:16060800-16065200 | Enhancers | Primary B cells from peripheral blood | blood |